My NCBI | Sign In
RSS Settings
  • Search: Lambert EA[au]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 22

    1.

    Sympathetic neural adaptation to hypocaloric diet with or without exercise training in obese metabolic syndrome subjects.

    Straznicky NE, Lambert EA, Nestel PJ, McGrane MT, Dawood T, Schlaich MP, Masuo K, Eikelis N, de Courten B, Mariani JA, Esler MD, Socratous F, Chopra R, Sari CI, Paul E, Lambert GW.

    Diabetes. 2009 Oct 15. [Epub ahead of print]PMID: 19833893 [PubMed - as supplied by publisher]Related articles

    2.

    Neuroadrenergic dysfunction in obesity: an overview of the effects of weight loss.

    Straznicky NE, Lambert GW, Lambert EA.

    Curr Opin Lipidol. 2009 Oct 3. [Epub ahead of print]PMID: 19809312 [PubMed - as supplied by publisher]Related articles

    3.

    Short-term heart rate variability and cardiac norepinephrine spillover in patients with depression and panic disorder.

    Baumert M, Lambert GW, Dawood T, Lambert EA, Esler MD, McGrane M, Barton D, Sanders P, Nalivaiko E.

    Am J Physiol Heart Circ Physiol. 2009 Aug;297(2):H674-9. Epub 2009 Jun 5.PMID: 19502559 [PubMed - indexed for MEDLINE]Related articles

    4.

    Weight loss may reverse blunted sympathetic neural responsiveness to glucose ingestion in obese subjects with metabolic syndrome.

    Straznicky NE, Lambert GW, McGrane MT, Masuo K, Dawood T, Nestel PJ, Eikelis N, Schlaich MP, Esler MD, Socratous F, Chopra R, Lambert EA.

    Diabetes. 2009 May;58(5):1126-32. Epub 2009 Feb 2.PMID: 19188428 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    European Society of Hypertension Working Group on Obesity Obesity-induced hypertension and target organ damage: current knowledge and future directions.

    Schlaich MP, Grassi G, Lambert GW, Straznicky N, Esler MD, Dixon J, Lambert EA, Redon J, Narkiewicz K, Jordan J; European Society of Hypertension Working Group on Obesity; Australian and New Zealand Obesity Society.

    J Hypertens. 2009 Feb;27(2):207-11. No abstract available. PMID: 19155773 [PubMed - indexed for MEDLINE]Related articles

    6.

    Blunted sympathetic neural response to oral glucose in obese subjects with the insulin-resistant metabolic syndrome.

    Straznicky NE, Lambert GW, Masuo K, Dawood T, Eikelis N, Nestel PJ, McGrane MT, Mariani JA, Socratous F, Chopra R, Esler MD, Schlaich MP, Lambert EA.

    Am J Clin Nutr. 2009 Jan;89(1):27-36. Epub 2008 Dec 3.PMID: 19056585 [PubMed - indexed for MEDLINE]Related articles

    7.

    Mediators of sympathetic activation in metabolic syndrome obesity.

    Straznicky NE, Eikelis N, Lambert EA, Esler MD.

    Curr Hypertens Rep. 2008 Dec;10(6):440-7. Review.PMID: 18959829 [PubMed - indexed for MEDLINE]Related articles

    8.

    The Bacillus anthracis SleL (YaaH) protein is an N-acetylglucosaminidase involved in spore cortex depolymerization.

    Lambert EA, Popham DL.

    J Bacteriol. 2008 Dec;190(23):7601-7. Epub 2008 Oct 3.PMID: 18835992 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Sympathetic activation in chronic renal failure.

    Schlaich MP, Socratous F, Hennebry S, Eikelis N, Lambert EA, Straznicky N, Esler MD, Lambert GW.

    J Am Soc Nephrol. 2009 May;20(5):933-9. Epub 2008 Sep 17. Review.PMID: 18799718 [PubMed - indexed for MEDLINE]Related articles

    10.

    Leptin-receptor polymorphisms relate to obesity through blunted leptin-mediated sympathetic nerve activation in a Caucasian male population.

    Masuo K, Straznicky NE, Lambert GW, Katsuya T, Sugimoto K, Rakugi H, Socratous F, Hastings J, Lambert EA, Ogihara T, Esler MD.

    Hypertens Res. 2008 Jun;31(6):1093-100.PMID: 18716356 [PubMed - indexed for MEDLINE]Related articles

    11.

    QT interval variability and cardiac norepinephrine spillover in patients with depression and panic disorder.

    Baumert M, Lambert GW, Dawood T, Lambert EA, Esler MD, McGrane M, Barton D, Nalivaiko E.

    Am J Physiol Heart Circ Physiol. 2008 Sep;295(3):H962-H968. Epub 2008 Jul 3.PMID: 18599596 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Elevated brain serotonin turnover in patients with depression: effect of genotype and therapy.

    Barton DA, Esler MD, Dawood T, Lambert EA, Haikerwal D, Brenchley C, Socratous F, Hastings J, Guo L, Wiesner G, Kaye DM, Bayles R, Schlaich MP, Lambert GW.

    Arch Gen Psychiatry. 2008 Jan;65(1):38-46.PMID: 18180427 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Elevated cardiac risk in patients with major depressive disorder.

    Bayles RG, Dawood T, Lambert EA, Schlaich MP, Lambert GW.

    Am J Psychiatry. 2008 Jan;165(1):137; author reply 137-8. No abstract available. PMID: 18178758 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Letter by Schlaich et al regarding article, "Relationship between central sympathetic drive and magnetic resonance imaging determined left ventricular mass in essential hypertension".

    Schlaich MP, Lambert GW, Lambert EA, Esler MD.

    Circulation. 2007 Oct 23;116(17):e416; author reply e417. No abstract available. PMID: 17965398 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Sympathetic activity in major depressive disorder: identifying those at increased cardiac risk?

    Barton DA, Dawood T, Lambert EA, Esler MD, Haikerwal D, Brenchley C, Socratous F, Kaye DM, Schlaich MP, Hickie I, Lambert GW.

    J Hypertens. 2007 Oct;25(10):2117-24.PMID: 17885556 [PubMed - indexed for MEDLINE]Related articles

    16.

    Specific serotonin reuptake inhibition in major depressive disorder adversely affects novel markers of cardiac risk.

    Dawood T, Lambert EA, Barton DA, Laude D, Elghozi JL, Esler MD, Haikerwal D, Kaye DM, Hotchkin EJ, Lambert GW.

    Hypertens Res. 2007 Apr;30(4):285-93.PMID: 17541206 [PubMed - indexed for MEDLINE]Related articles

    17.

    Sympathetic hyperactivity in hypertensive chronic kidney disease patients is reduced during standard treatment.

    Schlaich MP, Lambert EA, Sobotka PA, Lambert GW, Esler MD.

    Hypertension. 2007 May;49(5):e27; author reply e28. Epub 2007 Mar 5. No abstract available. PMID: 17339531 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Effects of dietary weight loss on sympathetic activity and cardiac risk factors associated with the metabolic syndrome.

    Straznicky NE, Lambert EA, Lambert GW, Masuo K, Esler MD, Nestel PJ.

    J Clin Endocrinol Metab. 2005 Nov;90(11):5998-6005. Epub 2005 Aug 9.PMID: 16091482 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Reduced sympathoneural responses to the cold pressor test in individuals with essential hypertension and in those genetically predisposed to hypertension. No support for the "pressor reactor" hypothesis of hypertension development.

    Lambert EA, Schlaich MP.

    Am J Hypertens. 2004 Oct;17(10):863-8.PMID: 15485746 [PubMed - indexed for MEDLINE]Related articles

    20.

    Sympathetic and cardiac baroreflex function in panic disorder.

    Lambert EA, Thompson J, Schlaich M, Laude D, Elghozi JL, Esler MD, Lambert GW.

    J Hypertens. 2002 Dec;20(12):2445-51.PMID: 12473870 [PubMed - indexed for MEDLINE]Related articles

    21.

    Comparing spectral and invasive estimates of baroreflex gain.

    Head GA, Lukoshkova EV, Burke SL, Malpas SC, Lambert EA, Janssen BJ.

    IEEE Eng Med Biol Mag. 2001 Mar-Apr;20(2):43-52. No abstract available. PMID: 11321719 [PubMed - indexed for MEDLINE]Related articles

    22.

    Teratogenicity in swine of the tobacco alkaloid anabasine isolated from Nicotiana glauca.

    Keeler RF, Crowe MW, Lambert EA.

    Teratology. 1984 Aug;30(1):61-9.PMID: 6484853 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    1 free full-text article in PubMed Central

    Find related data

    Search details

    » See more...

    Recent activity